KRO KRONOS WORLDWIDE INC
Industrial Inorganic Chemicals · NYSE · SEC CIK 1257640 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.7%
TTM net income YoY9.0%
TTM EPS YoY5.7%
Revenue 3-yr CAGR8.0%
Net income 3-yr CAGR—
Margins
Gross margin15.3%
Operating margin2.2%
Net margin-1.9%
FCF margin—
EBITDA margin5.3%
Returns
ROE-4.7%
ROA-2.1%
ROIC (approx.)2.6%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.69x
Current ratio3.30x
Interest coverage0.80x
Cash quality & payout
Operating cash flow / net income-3.91x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.86B | $1.89B | $1.67B | $1.93B | $1.94B |
| Cost of revenue | $1.65B | $1.53B | $1.50B | $1.54B | $1.49B |
| Gross profit | $213.00M | $359.30M | $164.90M | $391.10M | $446.20M |
| R&D expense | $16.00M | $14.00M | $18.00M | $15.00M | $17.00M |
| SG&A expense | $245.20M | $225.60M | $211.20M | $231.30M | $248.90M |
| Operating income | -$36.50M | $122.90M | -$56.00M | $159.60M | $187.10M |
| Interest expense | $53.00M | $42.90M | $17.10M | $16.90M | $19.60M |
| Pretax income | -$97.40M | $149.60M | -$72.90M | $133.90M | $153.40M |
| Income tax | $13.50M | $63.40M | -$23.80M | $29.40M | $40.50M |
| Net income | -$110.90M | $86.20M | -$49.10M | $104.50M | $112.90M |
| EBITDA | $24.00M | $183.30M | -$7.40M | $211.30M | $238.40M |
| EPS (basic) | -0.96 | 0.75 | -0.43 | 0.90 | 0.98 |
| EPS (diluted) | -0.96 | 0.75 | -0.43 | 0.90 | 0.98 |
| Dividends declared per share | 0.20 | 0.48 | 0.76 | 0.76 | 0.72 |
| Weighted avg. shares (diluted) | 115.00M | 115.00M | 115.10M | 115.50M | 116 |
| Balance sheet | |||||
| Cash & equivalents | $33.20M | $114.70M | $202.10M | $334.60M | $412.60M |
| Receivables | — | $291.60M | $295.20M | $252.40M | $360.70M |
| Inventory | $628.60M | $656.70M | $564.60M | $608.70M | $432.30M |
| Current assets | $994.50M | $1.11B | $1.12B | $1.24B | $1.26B |
| PP&E, net | $724.30M | $694.10M | $482.90M | $484.50M | $503.40M |
| Goodwill | $2.60M | $2.60M | — | — | — |
| Total assets | $1.82B | $1.91B | $1.84B | $1.93B | $2.01B |
| Current liabilities | $368.80M | $476.60M | $370.80M | $326.70M | $288.80M |
| Short-term debt | — | $78.30M | — | $1.10M | $1.40M |
| Long-term debt | $557.40M | $429.10M | $440.90M | $424.10M | $449.80M |
| Total debt | $557.40M | $507.40M | $440.90M | $425.20M | $451.20M |
| Total liabilities | $1.07B | $1.10B | $1.03B | $977.20M | $1.14B |
| Shareholders' equity | $751.10M | $817.00M | $808.30M | $957.20M | $870.20M |
| Net debt | $524.20M | $392.70M | $238.80M | $90.60M | $38.60M |
| Shares outstanding | 115.00M | 115.00M | 115.00M | 115.10M | 115.50M |
| Cash flow statement | |||||
| Operating cash flow | $2.50M | $72.50M | $5.50M | $81.70M | $206.50M |
| Capital expenditure | $42.90M | $29.50M | $47.40M | $63.20M | $58.60M |
| Free cash flow | -$40.40M | $43.00M | -$41.90M | $18.50M | $147.90M |
| Investing cash flow | -$42.90M | -$186.30M | -$47.40M | -$63.10M | -$58.60M |
| Financing cash flow | -$36.30M | $26.50M | -$91.60M | -$91.50M | -$86.70M |
| Depreciation & amortization | $60.50M | $60.40M | $48.60M | $51.70M | $51.30M |
| Dividends paid | $23.00M | $55.20M | $87.50M | $87.80M | $83.20M |
| Share buybacks | — | — | $2.90M | $2.30M | $200,000 |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.